jueves, 16 de septiembre de 2021

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT - The Lancet Haematology

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT - The Lancet Haematology

No hay comentarios:

Publicar un comentario